Priya Kalahasti, M.D.
| Appointed: |
2006 |
| Gender: |
Female |
| Languages: |
English
Hindi |
Nephrology and Hypertension
Biographical Sketch
Priya Kalahasti, MD, is a Clinical Associate in the Department of Nephrology and Hypertension at Cleveland Clinic's main campus. She is board-certified in internal medicine and nephrology. Dr. Kalahasti’s specialty interests include chronic kidney disease, glomerulonephritis, hemodialysis, peritoneal dialysis and hypertension.
A native of India, Dr. Kalahasti received her medical degree from the University of Health Sciences Sri Venkateswara Medical College in Tirupati, A.P., India. She received honors in biochemistry and a Gold Medal in pharmacology. She did a rotating internship at S.V.R. R. Government General Hospital in Tirupati, A.P. India. She followed this with an internship and residency in internal medicine at Cleveland Clinic. Dr. Kalahasti then accepted a fellowship in nephrology and hypertension from Cleveland Clinic.
Dr. Kalahasti is a member of the American Society of Nephrology, National Kidney Foundation and the American Medical Association.
Education & Fellowships
| Medical School: | Sri Venkatesvara University Medical College-Tirupati, Tirupati, India, India |
|
| Internship: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Residency: | Cleveland Clinic, Internal Medicine, Cleveland, OH |
| Fellowship: | Cleveland Clinic, Nephrology, Cleveland, OH |
Certifications
Nephrology
Internal Medicine
Professional Memberships
- American Society of Nephrology
- American College of Physicians
Specializes in Diseases and Conditions
Specializes in Services
Industry Relationships
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical education about recent trends. The collaborations are reviewed as part of the Cleveland Clinic’s procedures. The Cleveland Clinic publicly discloses payments to its physicians and scientists for speaking and consulting of $5,000 or more per year, and any equity, royalties, and fiduciary relationships in companies with which they collaborate. The Cleveland Clinic requires its doctors to approve the public disclosures of their scientific collaborations with industry. As of 10/24/2008 the review process regarding Dr. Kalahasti’s disclosure had not been completed. Patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic’s policies on collaborations with industry and innovation management, go to our
Integrity in Innovation page.
( † Disclaimer: This search is powered by PubMed, a service of the U.S.
National Library of Medicine. PubMed is a third-party website with no
affiliation with Cleveland Clinic.)
